Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: Implications on delayed parasite clearance

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Michael, Obaro S ^a   Gbotosho, Grace O ^a   Folarin, Onikepe A ^a   Okuboyejo, Titilope ^a   Sowunmi, Akintunde ^a   Oduola, Ayoade Mj ^b   Happi, Christian T ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; AMODIAQUINE, ARTESUNATE DRUG COMBINATION; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ABDOMINAL PAIN; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; DRUG TOLERANCE; FEMALE; GENETIC VARIABILITY; HEADACHE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MICROBIAL IDENTIFICATION; MICROBIAL KINETICS; MICROBIAL POPULATION DYNAMICS; NIGERIA; OPEN STUDY; PARASITE CLEARANCE; PARASITEMIA; PLASMODIUM FALCIPARUM; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; SCHOOL CHILD; TREATMENT RESPONSE; VOMITING; WEAKNESS; BLOOD; DRUG COMBINATION; ISOLATION AND PURIFICATION; PARASITOLOGY; PRESCHOOL CHILD; TIME;

AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; BLOOD; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; NIGERIA; PARASITEMIA; PLASMODIUM FALCIPARUM; TIME FACTORS;

EID: 78549279841     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-335     Document Type: Article

References (29)

1. Guidelines for the treatment of malaria. WHO, 2 2010 http://whqlibdoc. who.int/publications/2010/9789241547925-eng.pdf
2. Preventing antimalarial drug resistance through combinations. NJ White, Drug Resist Updat 1998 1 3 9 10.1016/S1368-7646(98)80208-2 17092790
3. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. RT Eastman DA Fidock, Nat Rev Microbiol 2009 7 864 874 19881520
4. A fixed-dose 24-hour regimen of artesunate plus sulfamethoxypyrazine- pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan. I Adam M Magzoub ME Osman IF Khalil M Alifrangis KA Elmardi, Ann Clin Microbiol Antimicrob 2006 5 18 10.1186/1476-0711-5-18 16934158
5. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. GO Adjei JA Kurtzhals OP Rodrigues M Alifrangis LC Hoegberg ED Kitcher EV Badoe R Lamptey BQ Goka, Malar J 2008 7 127 10.1186/1475-2875-7-127 18620577
6. An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. EA Ashley KM Lwin R McGready WH Simon L Phaiphun S Proux N Wangseang W Taylor K Stepniewska W Nawamaneerat KL Thwai M Barends W Leowattana P Olliaro P Singhasivanon NJ White F Nosten, Trop Med Int Health 2006 11 1653 1660 10.1111/j.1365-3156.2006.01724.x 17054744
7. High efficacy of two artemisinin-based combinations (artemether- lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria. CO Falade AO Ogundele BO Yusuf OG Ademowo SM Ladipo, Trop Med Int Health 2008 13 635 643 10.1111/j.1365-3156.2008.02043.x 18346028
8. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. B Faye JL Ndiaye D Ndiaye Y Dieng O Faye O Gaye, Malar J 2007 6 80 10.1186/1475-2875-6-80 17570848
9. Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan. AM Ibrahium MM Kheir ME Osman IF Khalil M Alifrangis KA Elmardi EM Malik I Adam, Ann Trop Med Parasitol 2007 101 15 21 10.1179/136485907X156924 17244406
10. Artemisinin-based combination treatment of falciparum malaria. F Nosten NJ White, Am J Trop Med Hyg 2007 77 181 192 18165491
11. Clinical pharmacology of artemisinin-based combination therapies. PI German FT Aweeka, Clin Pharmacokinet 2008 47 91 102 10.2165/00003088-200847020- 00002 18193915
12. Artemisinin resistance in Plasmodium falciparum malaria. AM Dondorp F Nosten P Yi D Das AP Phyo J Tarning KM Lwin F Ariey W Hanpithakpong SJ Lee P Ringwald K Silamut M Imwong K Chotivanich P Lim T Herdman SS An S Yeung P Singhasivanon NP Day N Lindegardh D Socheat NJ White, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
13. Evidence of artemisinin-resistant malaria in western Cambodia. H Noedl Y Se K Schaecher BL Smith D Socheat MM Fukuda, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
14. Artemisinin-resistant malaria in Asia. H Noedl D Socheat W Satimai, N Engl J Med 2009 361 540 541 10.1056/NEJMc0900231 19641219
15. Different methodological approaches to the assessment of n vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children. EA Ashley L Pinoges E Turyakira G Dorsey F Checchi H Bukirwa I van den Broek I Zongo PP Urruta M van Herp S Balkan WR Taylor P Olliaro JP Guthmann, Malar J 2008 7 154 10.1186/1475-2875-7-154 18691429
16. Assessment of the relative advantage of various artesunate-based combination therapies by a multi-treatment Bayesian random-effects meta-analysis. FH Jansen E Lesaffre LK Penali MJ Zattera H Die-Kakou E Bissagnene, Am J Trop Med Hyg 2007 77 1005 1009 18165512
17. Methods for surveillance of antimalarial drug efficacy. WHO, http://whqlibdoc.who.int/publications/2009/9789241597531-eng.pdf
18. Point mutations in the pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria. TC Happi SM Thomas GO Gbotosho CO Falade DO Akinboye L Gerena T Hudson A Sowunmi DE Kyle W Milhous DF Wirth AM Oduola, Ann Trop Med Parasitol 2003 97 439 451 10.1179/000349803235002489 12930607
19. Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria. CT Happi GO Gbotosho A Sowunmi CO Falade DO Akinboye L Gerena DE Kyle W Milhous DF Wirth AM Oduola, Am J Trop Med Hyg 2004 70 20 26 14971693
20. Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda. J Mwesigwa S Parikh B McGee P German T Drysdale JN Kalyango TD Clark G Dorsey N Lindegardh A Annerberg PJ Rosenthal MR Kamya F Aweeka, Antimicrob Agents Chemother 2010 54 52 59 10.1128/AAC.00679-09
21. Artesunate-amodiaquine for the treatment of uncomplicated malaria. SB Sirima A Gansane, Expert Opin Investig Drugs 2007 16 1079 1085 10.1517/13543784.16.7.1079 17594191
22. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. S Abdulla I Sagara S Borrmann U D'Alessandro R Gonzalez M Hamel B Ogutu A Martensson J Lyimo H Maiga P Sasi A Nahum Q Bassat E Juma L Otieno A Björkman HP Beck K Andriano M Cousin G Lefèvre D Ubben Z Premji, Lancet 2008 372 1819 1827 10.1016/S0140-6736(08)61492-0 18926569
23. Artesunate combinations for treatment of malaria: meta-analysis. M Adjuik A Babiker P Garner P Olliaro W Taylor N White, Lancet 2004 363 9 17 10.1016/S0140-6736(03)15162-8 14723987
24. Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania. AM Kabanywanyi A Mwita D Sumari R Mandike K Mugittu S Abdulla, Malar J 2007 6 146 10.1186/1475-2875-6- 146 17996121
25. Artemisinin-based combination therapy for treating uncomplicated malaria. D Sinclair B Zani S Donegan P Olliaro P Garner, Cochrane Database Syst Rev 2009 D007483 19588433
26. Artemisinin derivatives for treating severe malaria. HM McIntosh P Olliaro, Cochrane Database Syst Rev 2000 D000527 10796551
27. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. NJ White, Antimicrob Agents Chemother 1997 41 1413 1422 9210658
28. Frequency of early rising parasitemia in falciparum malaria treated with artemisinin derivatives. U Silachamroon W Phumratanaprapin S Krudsood S Treeprasertsuk V Budsaratid K Pornpininworakij P Wilairatan S Looareesuwan, Southeast Asian J Trop Med Public Health 2001 32 50 56 11485095
29. Artemisinin and its derivatives: an important new class of antimalarial agents. GA Balint, Pharmacol Ther 2001 90 261 265 10.1016/S0163-7258(01)00140-1 11578659